These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 6435628)

  • 1. Isolation and characterization of N-acetylglucosamine 6-sulfate from the urine of a patient with Sanfilippo type D syndrome and its occurrence in normal urine.
    Hopwood JJ; Elliott H
    Biochem Int; 1983 Jun; 6(6):831-6. PubMed ID: 6435628
    [TBL] [Abstract][Full Text] [Related]  

  • 2. N-acetylglucosamine 6-sulfate residues in keratan sulfate and heparan sulfate are desulfated by the same enzyme.
    Hopwood JJ; Elliott H
    Biochem Int; 1983 Feb; 6(2):141-8. PubMed ID: 6236815
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urinary excretion of sulphated N-acetylhexosamines in patients with various mucopolysaccharidoses.
    Hopwood JJ; Elliott H
    Biochem J; 1985 Aug; 229(3):579-86. PubMed ID: 3931626
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of the Sanfilippo D syndrome by the use of a radiolabeled monosaccharide sulfate as the substrate for the estimation of N-acetylglucosamine-6-sulfate sulfatase.
    Elliott H; Hopwood JJ
    Anal Biochem; 1984 Apr; 138(1):205-9. PubMed ID: 6428270
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glycosaminoglycans analysis in blood and urine of patients with mucopolysaccharidosis.
    Khan SA; Mason RW; Giugliani R; Orii K; Fukao T; Suzuki Y; Yamaguchi S; Kobayashi H; Orii T; Tomatsu S
    Mol Genet Metab; 2018 Sep; 125(1-2):44-52. PubMed ID: 29779903
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intralysosomal formation and metabolic fate of N-acetylglucosamine 6-sulfate from keratan sulfate.
    Fuchs W; Beck M; Kresse H
    Eur J Biochem; 1985 Sep; 151(3):551-6. PubMed ID: 3161730
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A screening method for mucopolysaccharidoses with increased urinary excretion of sulfated N-acetylhexosamines.
    Nowakowski RW; Thompson JN; Edge DS
    Biochem Int; 1990 Nov; 22(3):419-26. PubMed ID: 2127527
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sanfilippo D syndrome: estimation of N-acetylglucosamine-6-sulfatase activity with a radiolabeled monosulfated disaccharide substrate.
    Freeman C; Hopwood JJ
    Anal Biochem; 1989 Feb; 176(2):244-8. PubMed ID: 2500866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deficiencies of glucosamine-6-sulfate or galactosamine-6-sulfate sulfatases are responsible for different mucopolysaccharidoses.
    Di Ferrante N; Ginsberg LC; Donnelly PV; Di Ferrante DT; Caskey CT
    Science; 1978 Jan; 199(4324):79-81. PubMed ID: 17569489
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rapid identification of San Filippo disease (MPS III).
    Kelly S; Schedlbauer L; Leikhim E
    Health Lab Sci; 1978 Jul; 15(3):123-7. PubMed ID: 151669
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differences in the nonreducing ends of heparan sulfates excreted by patients with mucopolysaccharidoses revealed by bacterial heparitinases: a new tool for structural studies and differential diagnosis of Sanfilippo's and Hunter's syndromes.
    Toma L; Dietrich CP; Nader HB
    Lab Invest; 1996 Dec; 75(6):771-81. PubMed ID: 8973472
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Characteristics of urinary heparan sulfate in 5 cases of Sanfilippo's syndrome].
    Fossati G; Sinigaglia F; Calatroni A
    Boll Soc Ital Biol Sper; 1974 Oct; 50(19):1552-8. PubMed ID: 4282024
    [No Abstract]   [Full Text] [Related]  

  • 13. Sanfilippo disease type D: deficiency of N-acetylglucosamine-6-sulfate sulfatase required for heparan sulfate degradation.
    Kresse H; Paschke E; von Figura K; Gilberg W; Fuchs W
    Proc Natl Acad Sci U S A; 1980 Nov; 77(11):6822-6. PubMed ID: 6450420
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sanfilippo syndrome, type D: a spectrophotometric assay with prenatal diagnostic potential.
    Nowakowski RW; Thompson JN; Taylor KB
    Pediatr Res; 1989 Nov; 26(5):462-6. PubMed ID: 2510119
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sanfilippo syndrome type D: natural history and identification of 3 novel mutations in the GNS Gene.
    Jansen AC; Cao H; Kaplan P; Silver K; Leonard G; De Meirleir L; Lissens W; Liebaers I; Veilleux M; Andermann F; Hegele RA; Andermann E
    Arch Neurol; 2007 Nov; 64(11):1629-34. PubMed ID: 17998446
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genomic basis of mucopolysaccharidosis type IIID (MIM 252940) revealed by sequencing of GNS encoding N-acetylglucosamine-6-sulfatase.
    Mok A; Cao H; Hegele RA
    Genomics; 2003 Jan; 81(1):1-5. PubMed ID: 12573255
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enzyme Replacement Therapy for Mucopolysaccharidosis IIID using Recombinant Human α-
    Wang F; Moen DR; Sauni C; Kan SH; Li S; Le SQ; Lomenick B; Zhang X; Ekins S; Singamsetty S; Wood J; Dickson PI; Chou TF
    Mol Pharm; 2021 Jan; 18(1):214-227. PubMed ID: 33320673
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic studies of glycosphingolipid accumulation in mucopolysaccharidosis IIID.
    Liour SS; Jones MZ; Suzuki M; Bieberich E; Yu RK
    Mol Genet Metab; 2001 Mar; 72(3):239-47. PubMed ID: 11243730
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glycosaminoglycan accumulation and excretion in the mucopolysaccharidoses: characterization and basis of a diagnostic test for MPS.
    Byers S; Rozaklis T; Brumfield LK; Ranieri E; Hopwood JJ
    Mol Genet Metab; 1998 Dec; 65(4):282-90. PubMed ID: 9889015
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aminosugar-containing low molecular weight acidic compounds present in urine of normal children and of patients affected by mucopolysaccharidosis type II, 3 or IV.
    Calatroni A; Pallavicini G; Castellani AA
    Ital J Biochem; 1974; 23(3):183-201. PubMed ID: 4214233
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.